> top > projects > spacy-test > docs > PubMed:3922093 > annotations
spacy-test Home  

PubMed:3922093 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-1 NNP denotes [
spaCy_T1 1-11 NNP denotes Sequential
spaCy_T2 12-28 NN denotes polychemotherapy
spaCy_T3 29-32 CC denotes and
spaCy_T4 33-44 JJ denotes large-field
spaCy_T5 45-57 NN denotes radiotherapy
spaCy_T6 58-60 IN denotes of
spaCy_T7 61-72 NNP denotes non-Hodgkin
spaCy_T8 72-74 POS denotes 's
spaCy_T9 75-83 NN denotes lymphoma
spaCy_T10 83-84 NNP denotes ]
spaCy_T11 84-85 . denotes .
spaCy_T12 86-89 DT denotes The
spaCy_T13 90-101 NN denotes combination
spaCy_T14 102-104 IN denotes of
spaCy_T15 105-121 JJ denotes polychemotherapy
spaCy_T16 122-125 CC denotes and
spaCy_T17 126-137 JJ denotes large-field
spaCy_T18 138-150 JJ denotes radiotherapy
spaCy_T19 151-162 RB denotes essentially
spaCy_T20 163-171 VBN denotes promoted
spaCy_T21 172-175 DT denotes the
spaCy_T22 176-184 VBN denotes improved
spaCy_T23 185-190 JJ denotes total
spaCy_T24 191-198 NNS denotes results
spaCy_T25 199-207 VBN denotes achieved
spaCy_T26 208-214 IN denotes during
spaCy_T27 215-218 DT denotes the
spaCy_T28 219-225 NN denotes period
spaCy_T29 226-228 IN denotes of
spaCy_T30 229-233 CD denotes 1976
spaCy_T31 234-237 CC denotes and
spaCy_T32 238-242 CD denotes 1982
spaCy_T33 243-245 IN denotes in
spaCy_T34 246-249 CD denotes 272
spaCy_T35 250-258 NNS denotes patients
spaCy_T36 259-263 IN denotes with
spaCy_T37 264-275 NNP denotes non-Hodgkin
spaCy_T38 275-277 POS denotes 's
spaCy_T39 278-287 NNS denotes lymphomas
spaCy_T40 288-289 -LRB- denotes (
spaCy_T41 289-292 NNP denotes NHL
spaCy_T42 292-293 -RRB- denotes )
spaCy_T43 294-296 IN denotes of
spaCy_T44 297-300 JJ denotes low
spaCy_T45 301-304 CC denotes and
spaCy_T46 305-309 JJ denotes high
spaCy_T47 310-320 NN denotes malignancy
spaCy_T48 320-321 . denotes .
spaCy_T49 322-324 IN denotes In
spaCy_T50 325-329 NN denotes case
spaCy_T51 330-332 IN denotes of
spaCy_T52 333-358 JJ denotes centroblastic-centrocytic
spaCy_T53 359-360 -LRB- denotes (
spaCy_T54 360-365 JJ denotes cb/cc
spaCy_T55 365-366 -RRB- denotes )
spaCy_T56 367-370 NNP denotes NHL
spaCy_T57 371-373 IN denotes of
spaCy_T58 374-380 NNS denotes stages
spaCy_T59 381-383 NNP denotes II
spaCy_T60 384-389 NNP denotes A/III
spaCy_T61 390-391 NNP denotes A
spaCy_T62 391-392 , denotes ,
spaCy_T63 393-396 DT denotes the
spaCy_T64 397-412 JJ denotes recurrence-free
spaCy_T65 413-421 NN denotes survival
spaCy_T66 422-427 IN denotes after
spaCy_T67 428-440 JJ denotes radiotherapy
spaCy_T68 441-442 -LRB- denotes (
spaCy_T69 442-443 JJ denotes n
spaCy_T70 444-445 SYM denotes =
spaCy_T71 446-448 CD denotes 21
spaCy_T72 448-449 -RRB- denotes )
spaCy_T73 450-455 MD denotes could
spaCy_T74 456-458 VB denotes be
spaCy_T75 459-468 VBN denotes increased
spaCy_T76 469-471 IN denotes by
spaCy_T77 472-475 DT denotes the
spaCy_T78 476-484 VBN denotes combined
spaCy_T79 485-491 NN denotes method
spaCy_T80 492-493 -LRB- denotes (
spaCy_T81 493-494 FW denotes n
spaCy_T82 495-496 SYM denotes =
spaCy_T83 497-499 CD denotes 25
spaCy_T84 499-500 -RRB- denotes )
spaCy_T85 501-505 IN denotes from
spaCy_T86 506-508 CD denotes 17
spaCy_T87 508-509 NN denotes %
spaCy_T88 510-512 TO denotes to
spaCy_T89 513-515 CD denotes 60
spaCy_T90 515-516 NN denotes %
spaCy_T91 516-517 , denotes ,
spaCy_T92 518-521 CC denotes and
spaCy_T93 522-525 DT denotes the
spaCy_T94 526-537 NN denotes probability
spaCy_T95 538-540 IN denotes of
spaCy_T96 541-551 JJ denotes seven-year
spaCy_T97 552-560 NN denotes survival
spaCy_T98 561-566 MD denotes could
spaCy_T99 567-569 VB denotes be
spaCy_T100 570-578 VBN denotes improved
spaCy_T101 579-583 IN denotes from
spaCy_T102 584-586 CD denotes 70
spaCy_T103 586-587 NN denotes %
spaCy_T104 588-590 TO denotes to
spaCy_T105 591-593 CD denotes 90
spaCy_T106 593-594 NN denotes %
spaCy_T107 594-595 . denotes .
spaCy_T108 596-599 DT denotes All
spaCy_T109 600-602 IN denotes of
spaCy_T110 603-606 DT denotes the
spaCy_T111 607-610 NN denotes ten
spaCy_T112 611-620 RB denotes initially
spaCy_T113 621-631 VBD denotes irradiated
spaCy_T114 632-640 NNS denotes patients
spaCy_T115 641-643 IN denotes in
spaCy_T116 644-647 DT denotes the
spaCy_T117 648-654 NNS denotes stages
spaCy_T118 655-656 PRP denotes I
spaCy_T119 657-661 VBP denotes A/II
spaCy_T120 662-667 NNP denotes A/III
spaCy_T121 668-669 NNP denotes A
spaCy_T122 670-672 IN denotes of
spaCy_T123 673-684 JJ denotes centrocytic
spaCy_T124 685-686 -LRB- denotes (
spaCy_T125 686-688 FW denotes cc
spaCy_T126 688-689 -RRB- denotes )
spaCy_T127 690-693 NNP denotes NHL
spaCy_T128 694-702 VBD denotes suffered
spaCy_T129 703-707 IN denotes from
spaCy_T130 708-709 DT denotes a
spaCy_T131 710-720 NN denotes recurrence
spaCy_T132 720-721 , denotes ,
spaCy_T133 722-729 IN denotes whereas
spaCy_T134 730-733 DT denotes the
spaCy_T135 734-745 NN denotes development
spaCy_T136 746-751 VBZ denotes seems
spaCy_T137 752-754 TO denotes to
spaCy_T138 755-757 VB denotes be
spaCy_T139 758-762 RBR denotes more
spaCy_T140 763-772 JJ denotes favorable
spaCy_T141 773-775 IN denotes in
spaCy_T142 776-779 DT denotes the
spaCy_T143 780-784 CD denotes five
spaCy_T144 785-793 NNS denotes patients
spaCy_T145 794-803 VBD denotes submitted
spaCy_T146 804-806 TO denotes to
spaCy_T147 807-815 VBN denotes combined
spaCy_T148 816-825 NN denotes treatment
spaCy_T149 826-829 WP denotes who
spaCy_T150 830-833 VBD denotes had
spaCy_T151 834-838 RB denotes only
spaCy_T152 839-842 CD denotes one
spaCy_T153 843-853 NN denotes recurrence
spaCy_T154 853-854 . denotes .
spaCy_T155 855-858 DT denotes The
spaCy_T156 859-874 JJ denotes recurrence-free
spaCy_T157 875-885 JJ denotes seven-year
spaCy_T158 886-894 NN denotes survival
spaCy_T159 895-897 IN denotes of
spaCy_T160 898-901 DT denotes the
spaCy_T161 902-908 RB denotes highly
spaCy_T162 909-918 JJ denotes malignant
spaCy_T163 919-922 NNP denotes NHL
spaCy_T164 923-925 IN denotes in
spaCy_T165 926-931 NN denotes stage
spaCy_T166 932-933 PRP denotes I
spaCy_T167 934-938 VBP denotes A/II
spaCy_T168 939-940 DT denotes A
spaCy_T169 941-950 VBN denotes increased
spaCy_T170 951-955 IN denotes from
spaCy_T171 956-958 CD denotes 40
spaCy_T172 958-959 NN denotes %
spaCy_T173 960-965 IN denotes after
spaCy_T174 966-972 JJ denotes unique
spaCy_T175 973-985 NN denotes radiotherapy
spaCy_T176 986-987 -LRB- denotes (
spaCy_T177 987-988 FW denotes n
spaCy_T178 989-990 SYM denotes =
spaCy_T179 991-993 CD denotes 15
spaCy_T180 993-994 -RRB- denotes )
spaCy_T181 995-997 TO denotes to
spaCy_T182 998-1000 CD denotes 70
spaCy_T183 1000-1001 NN denotes %
spaCy_T184 1002-1007 IN denotes after
spaCy_T185 1008-1016 VBN denotes combined
spaCy_T186 1017-1024 NN denotes therapy
spaCy_T187 1025-1026 -LRB- denotes (
spaCy_T188 1026-1027 FW denotes n
spaCy_T189 1028-1029 SYM denotes =
spaCy_T190 1030-1032 CD denotes 39
spaCy_T191 1032-1033 -RRB- denotes )
spaCy_T192 1033-1034 , denotes ,
spaCy_T193 1035-1038 DT denotes the
spaCy_T194 1039-1047 NN denotes survival
spaCy_T195 1048-1059 NN denotes probability
spaCy_T196 1060-1069 VBD denotes increased
spaCy_T197 1070-1074 IN denotes from
spaCy_T198 1075-1077 CD denotes 55
spaCy_T199 1077-1078 NN denotes %
spaCy_T200 1079-1081 TO denotes to
spaCy_T201 1082-1084 CD denotes 75
spaCy_T202 1084-1085 NN denotes %
spaCy_T203 1085-1086 . denotes .
spaCy_T204 1087-1094 IN denotes Despite
spaCy_T205 1095-1098 DT denotes the
spaCy_T206 1099-1105 RB denotes partly
spaCy_T207 1106-1118 JJ denotes insufficient
spaCy_T208 1119-1126 NN denotes therapy
spaCy_T209 1127-1134 NNS denotes results
spaCy_T210 1135-1140 IN denotes after
spaCy_T211 1141-1147 JJ denotes unique
spaCy_T212 1148-1160 NN denotes radiotherapy
spaCy_T213 1161-1164 CC denotes and
spaCy_T214 1165-1181 NN denotes polychemotherapy
spaCy_T215 1181-1182 , denotes ,
spaCy_T216 1183-1186 DT denotes the
spaCy_T217 1187-1195 VBN denotes combined
spaCy_T218 1196-1202 NN denotes method
spaCy_T219 1203-1206 VBZ denotes has
spaCy_T220 1207-1214 RB denotes largely
spaCy_T221 1215-1226 VBN denotes contributed
spaCy_T222 1227-1229 TO denotes to
spaCy_T223 1230-1237 VB denotes achieve
spaCy_T224 1238-1243 IN denotes after
spaCy_T225 1244-1249 CD denotes eight
spaCy_T226 1250-1255 NNS denotes years
spaCy_T227 1256-1259 DT denotes the
spaCy_T228 1260-1265 JJ denotes total
spaCy_T229 1266-1274 NN denotes survival
spaCy_T230 1275-1280 NNS denotes rates
spaCy_T231 1281-1283 IN denotes of
spaCy_T232 1284-1286 CD denotes 76
spaCy_T233 1286-1287 NN denotes %
spaCy_T234 1288-1291 IN denotes for
spaCy_T235 1292-1297 JJ denotes cb/cc
spaCy_T236 1298-1301 NNP denotes NHL
spaCy_T237 1302-1303 -LRB- denotes (
spaCy_T238 1303-1304 FW denotes n
spaCy_T239 1305-1306 SYM denotes =
spaCy_T240 1307-1310 CD denotes 123
spaCy_T241 1310-1311 -RRB- denotes )
spaCy_T242 1312-1315 CC denotes and
spaCy_T243 1316-1318 IN denotes of
spaCy_T244 1319-1321 CD denotes 55
spaCy_T245 1321-1322 NN denotes %
spaCy_T246 1323-1326 IN denotes for
spaCy_T247 1327-1330 DT denotes the
spaCy_T248 1331-1337 RB denotes highly
spaCy_T249 1338-1347 JJ denotes malignant
spaCy_T250 1348-1361 JJ denotes immunoblastic
spaCy_T251 1362-1365 NNP denotes NHL
spaCy_T252 1366-1367 -LRB- denotes (
spaCy_T253 1367-1368 FW denotes n
spaCy_T254 1369-1370 SYM denotes =
spaCy_T255 1371-1373 CD denotes 57
spaCy_T256 1373-1374 -RRB- denotes )
spaCy_T257 1374-1375 , denotes ,
spaCy_T258 1376-1389 JJ denotes centroblastic
spaCy_T259 1390-1393 NNP denotes NHL
spaCy_T260 1394-1395 -LRB- denotes (
spaCy_T261 1395-1396 FW denotes n
spaCy_T262 1397-1398 SYM denotes =
spaCy_T263 1399-1401 CD denotes 35
spaCy_T264 1401-1402 -RRB- denotes )
spaCy_T265 1403-1406 CC denotes and
spaCy_T266 1407-1410 NNP denotes NHL
spaCy_T267 1411-1415 IN denotes with
spaCy_T268 1416-1425 JJ denotes uncertain
spaCy_T269 1426-1440 NN denotes classification
spaCy_T270 1440-1441 , denotes ,
spaCy_T271 1442-1449 IN denotes whereas
spaCy_T272 1450-1453 DT denotes the
spaCy_T273 1454-1460 NNP denotes cc-NHL
spaCy_T274 1461-1462 -LRB- denotes (
spaCy_T275 1462-1463 FW denotes n
spaCy_T276 1464-1465 SYM denotes =
spaCy_T277 1466-1468 CD denotes 36
spaCy_T278 1468-1469 -RRB- denotes )
spaCy_T279 1470-1478 NN denotes hitherto
spaCy_T280 1479-1482 VBZ denotes has
spaCy_T281 1483-1484 DT denotes a
spaCy_T282 1485-1495 RB denotes relatively
spaCy_T283 1496-1507 JJ denotes unfavorable
spaCy_T284 1508-1517 NN denotes prognosis
spaCy_T285 1518-1522 IN denotes with
spaCy_T286 1523-1527 JJ denotes only
spaCy_T287 1528-1530 CD denotes 29
spaCy_T288 1530-1531 NN denotes %
spaCy_T289 1531-1532 . denotes .
spaCy_R0 spaCy_T0 spaCy_T2 compound [,polychemotherapy
spaCy_R1 spaCy_T1 spaCy_T2 compound Sequential,polychemotherapy
spaCy_R10 spaCy_T10 spaCy_T6 pobj ],of
spaCy_R100 spaCy_T100 spaCy_T75 conj improved,increased
spaCy_R101 spaCy_T101 spaCy_T100 prep from,improved
spaCy_R102 spaCy_T102 spaCy_T103 nummod 70,%
spaCy_R103 spaCy_T103 spaCy_T101 pobj %,from
spaCy_R104 spaCy_T104 spaCy_T100 prep to,improved
spaCy_R105 spaCy_T105 spaCy_T106 nummod 90,%
spaCy_R106 spaCy_T106 spaCy_T104 pobj %,to
spaCy_R107 spaCy_T107 spaCy_T100 punct .,improved
spaCy_R108 spaCy_T108 spaCy_T113 nsubj All,irradiated
spaCy_R109 spaCy_T109 spaCy_T108 prep of,All
spaCy_R11 spaCy_T11 spaCy_T2 punct .,polychemotherapy
spaCy_R110 spaCy_T110 spaCy_T111 det the,ten
spaCy_R111 spaCy_T111 spaCy_T109 pobj ten,of
spaCy_R112 spaCy_T112 spaCy_T113 advmod initially,irradiated
spaCy_R113 spaCy_T113 spaCy_T113 ROOT irradiated,irradiated
spaCy_R114 spaCy_T114 spaCy_T113 dobj patients,irradiated
spaCy_R115 spaCy_T115 spaCy_T113 prep in,irradiated
spaCy_R116 spaCy_T116 spaCy_T117 det the,stages
spaCy_R117 spaCy_T117 spaCy_T115 pobj stages,in
spaCy_R118 spaCy_T118 spaCy_T119 nsubj I,A/II
spaCy_R119 spaCy_T119 spaCy_T121 compound A/II,A
spaCy_R12 spaCy_T12 spaCy_T13 det The,combination
spaCy_R120 spaCy_T120 spaCy_T121 compound A/III,A
spaCy_R121 spaCy_T121 spaCy_T128 dobj A,suffered
spaCy_R122 spaCy_T122 spaCy_T121 prep of,A
spaCy_R123 spaCy_T123 spaCy_T122 pobj centrocytic,of
spaCy_R124 spaCy_T124 spaCy_T123 punct (,centrocytic
spaCy_R125 spaCy_T125 spaCy_T123 appos cc,centrocytic
spaCy_R126 spaCy_T126 spaCy_T123 punct ),centrocytic
spaCy_R127 spaCy_T127 spaCy_T128 nsubj NHL,suffered
spaCy_R128 spaCy_T128 spaCy_T113 conj suffered,irradiated
spaCy_R129 spaCy_T129 spaCy_T128 prep from,suffered
spaCy_R13 spaCy_T13 spaCy_T20 nsubj combination,promoted
spaCy_R130 spaCy_T130 spaCy_T131 det a,recurrence
spaCy_R131 spaCy_T131 spaCy_T129 pobj recurrence,from
spaCy_R132 spaCy_T132 spaCy_T128 punct ",",suffered
spaCy_R133 spaCy_T133 spaCy_T136 mark whereas,seems
spaCy_R134 spaCy_T134 spaCy_T135 det the,development
spaCy_R135 spaCy_T135 spaCy_T136 nsubj development,seems
spaCy_R136 spaCy_T136 spaCy_T128 advcl seems,suffered
spaCy_R137 spaCy_T137 spaCy_T138 aux to,be
spaCy_R138 spaCy_T138 spaCy_T136 xcomp be,seems
spaCy_R139 spaCy_T139 spaCy_T140 advmod more,favorable
spaCy_R14 spaCy_T14 spaCy_T13 prep of,combination
spaCy_R140 spaCy_T140 spaCy_T138 acomp favorable,be
spaCy_R141 spaCy_T141 spaCy_T140 prep in,favorable
spaCy_R142 spaCy_T142 spaCy_T144 det the,patients
spaCy_R143 spaCy_T143 spaCy_T144 nummod five,patients
spaCy_R144 spaCy_T144 spaCy_T141 pobj patients,in
spaCy_R145 spaCy_T145 spaCy_T128 conj submitted,suffered
spaCy_R146 spaCy_T146 spaCy_T145 prep to,submitted
spaCy_R147 spaCy_T147 spaCy_T148 amod combined,treatment
spaCy_R148 spaCy_T148 spaCy_T146 pobj treatment,to
spaCy_R149 spaCy_T149 spaCy_T150 nsubj who,had
spaCy_R15 spaCy_T15 spaCy_T20 nsubj polychemotherapy,promoted
spaCy_R150 spaCy_T150 spaCy_T148 relcl had,treatment
spaCy_R151 spaCy_T151 spaCy_T152 advmod only,one
spaCy_R152 spaCy_T152 spaCy_T153 nummod one,recurrence
spaCy_R153 spaCy_T153 spaCy_T150 dobj recurrence,had
spaCy_R154 spaCy_T154 spaCy_T128 punct .,suffered
spaCy_R155 spaCy_T155 spaCy_T158 det The,survival
spaCy_R156 spaCy_T156 spaCy_T158 amod recurrence-free,survival
spaCy_R157 spaCy_T157 spaCy_T158 amod seven-year,survival
spaCy_R158 spaCy_T158 spaCy_T158 ROOT survival,survival
spaCy_R159 spaCy_T159 spaCy_T158 prep of,survival
spaCy_R16 spaCy_T16 spaCy_T15 cc and,polychemotherapy
spaCy_R160 spaCy_T160 spaCy_T163 det the,NHL
spaCy_R161 spaCy_T161 spaCy_T162 advmod highly,malignant
spaCy_R162 spaCy_T162 spaCy_T163 amod malignant,NHL
spaCy_R163 spaCy_T163 spaCy_T159 pobj NHL,of
spaCy_R164 spaCy_T164 spaCy_T158 prep in,survival
spaCy_R165 spaCy_T165 spaCy_T164 pobj stage,in
spaCy_R166 spaCy_T166 spaCy_T167 nsubj I,A/II
spaCy_R167 spaCy_T167 spaCy_T158 relcl A/II,survival
spaCy_R168 spaCy_T168 spaCy_T169 nsubj A,increased
spaCy_R169 spaCy_T169 spaCy_T169 ROOT increased,increased
spaCy_R17 spaCy_T17 spaCy_T18 compound large-field,radiotherapy
spaCy_R170 spaCy_T170 spaCy_T169 prep from,increased
spaCy_R171 spaCy_T171 spaCy_T172 nummod 40,%
spaCy_R172 spaCy_T172 spaCy_T170 pobj %,from
spaCy_R173 spaCy_T173 spaCy_T169 prep after,increased
spaCy_R174 spaCy_T174 spaCy_T175 amod unique,radiotherapy
spaCy_R175 spaCy_T175 spaCy_T173 pobj radiotherapy,after
spaCy_R176 spaCy_T176 spaCy_T179 punct (,15
spaCy_R177 spaCy_T177 spaCy_T179 nmod n,15
spaCy_R178 spaCy_T178 spaCy_T179 punct =,15
spaCy_R179 spaCy_T179 spaCy_T175 appos 15,radiotherapy
spaCy_R18 spaCy_T18 spaCy_T15 conj radiotherapy,polychemotherapy
spaCy_R180 spaCy_T180 spaCy_T169 punct ),increased
spaCy_R181 spaCy_T181 spaCy_T169 prep to,increased
spaCy_R182 spaCy_T182 spaCy_T183 nummod 70,%
spaCy_R183 spaCy_T183 spaCy_T181 pobj %,to
spaCy_R184 spaCy_T184 spaCy_T169 prep after,increased
spaCy_R185 spaCy_T185 spaCy_T186 amod combined,therapy
spaCy_R186 spaCy_T186 spaCy_T184 pobj therapy,after
spaCy_R187 spaCy_T187 spaCy_T190 punct (,39
spaCy_R188 spaCy_T188 spaCy_T189 meta n,=
spaCy_R189 spaCy_T189 spaCy_T190 punct =,39
spaCy_R19 spaCy_T19 spaCy_T20 advmod essentially,promoted
spaCy_R190 spaCy_T190 spaCy_T186 appos 39,therapy
spaCy_R191 spaCy_T191 spaCy_T186 punct ),therapy
spaCy_R192 spaCy_T192 spaCy_T196 punct ",",increased
spaCy_R193 spaCy_T193 spaCy_T195 det the,probability
spaCy_R194 spaCy_T194 spaCy_T195 compound survival,probability
spaCy_R195 spaCy_T195 spaCy_T196 nsubj probability,increased
spaCy_R196 spaCy_T196 spaCy_T169 conj increased,increased
spaCy_R197 spaCy_T197 spaCy_T196 prep from,increased
spaCy_R198 spaCy_T198 spaCy_T199 nummod 55,%
spaCy_R199 spaCy_T199 spaCy_T197 pobj %,from
spaCy_R2 spaCy_T2 spaCy_T2 ROOT polychemotherapy,polychemotherapy
spaCy_R20 spaCy_T20 spaCy_T20 ROOT promoted,promoted
spaCy_R200 spaCy_T200 spaCy_T196 prep to,increased
spaCy_R201 spaCy_T201 spaCy_T202 nummod 75,%
spaCy_R202 spaCy_T202 spaCy_T200 pobj %,to
spaCy_R203 spaCy_T203 spaCy_T196 punct .,increased
spaCy_R204 spaCy_T204 spaCy_T221 prep Despite,contributed
spaCy_R205 spaCy_T205 spaCy_T209 det the,results
spaCy_R206 spaCy_T206 spaCy_T207 advmod partly,insufficient
spaCy_R207 spaCy_T207 spaCy_T209 amod insufficient,results
spaCy_R208 spaCy_T208 spaCy_T209 compound therapy,results
spaCy_R209 spaCy_T209 spaCy_T204 pobj results,Despite
spaCy_R21 spaCy_T21 spaCy_T24 det the,results
spaCy_R210 spaCy_T210 spaCy_T209 prep after,results
spaCy_R211 spaCy_T211 spaCy_T212 amod unique,radiotherapy
spaCy_R212 spaCy_T212 spaCy_T221 advcl radiotherapy,contributed
spaCy_R213 spaCy_T213 spaCy_T212 cc and,radiotherapy
spaCy_R214 spaCy_T214 spaCy_T212 conj polychemotherapy,radiotherapy
spaCy_R215 spaCy_T215 spaCy_T221 punct ",",contributed
spaCy_R216 spaCy_T216 spaCy_T218 det the,method
spaCy_R217 spaCy_T217 spaCy_T218 amod combined,method
spaCy_R218 spaCy_T218 spaCy_T221 nsubj method,contributed
spaCy_R219 spaCy_T219 spaCy_T221 aux has,contributed
spaCy_R22 spaCy_T22 spaCy_T24 amod improved,results
spaCy_R220 spaCy_T220 spaCy_T221 advmod largely,contributed
spaCy_R221 spaCy_T221 spaCy_T221 ROOT contributed,contributed
spaCy_R222 spaCy_T222 spaCy_T223 aux to,achieve
spaCy_R223 spaCy_T223 spaCy_T221 xcomp achieve,contributed
spaCy_R224 spaCy_T224 spaCy_T223 prep after,achieve
spaCy_R225 spaCy_T225 spaCy_T226 nummod eight,years
spaCy_R226 spaCy_T226 spaCy_T224 pobj years,after
spaCy_R227 spaCy_T227 spaCy_T230 det the,rates
spaCy_R228 spaCy_T228 spaCy_T230 amod total,rates
spaCy_R229 spaCy_T229 spaCy_T230 compound survival,rates
spaCy_R23 spaCy_T23 spaCy_T24 amod total,results
spaCy_R230 spaCy_T230 spaCy_T223 dobj rates,achieve
spaCy_R231 spaCy_T231 spaCy_T230 prep of,rates
spaCy_R232 spaCy_T232 spaCy_T233 nummod 76,%
spaCy_R233 spaCy_T233 spaCy_T231 pobj %,of
spaCy_R234 spaCy_T234 spaCy_T233 prep for,%
spaCy_R235 spaCy_T235 spaCy_T236 compound cb/cc,NHL
spaCy_R236 spaCy_T236 spaCy_T234 pobj NHL,for
spaCy_R237 spaCy_T237 spaCy_T230 punct (,rates
spaCy_R238 spaCy_T238 spaCy_T240 advmod n,123
spaCy_R239 spaCy_T239 spaCy_T240 punct =,123
spaCy_R24 spaCy_T24 spaCy_T20 dobj results,promoted
spaCy_R240 spaCy_T240 spaCy_T230 appos 123,rates
spaCy_R241 spaCy_T241 spaCy_T240 punct ),123
spaCy_R242 spaCy_T242 spaCy_T240 cc and,123
spaCy_R243 spaCy_T243 spaCy_T244 quantmod of,55
spaCy_R244 spaCy_T244 spaCy_T240 conj 55,123
spaCy_R245 spaCy_T245 spaCy_T244 quantmod %,55
spaCy_R246 spaCy_T246 spaCy_T244 prep for,55
spaCy_R247 spaCy_T247 spaCy_T251 det the,NHL
spaCy_R248 spaCy_T248 spaCy_T249 advmod highly,malignant
spaCy_R249 spaCy_T249 spaCy_T251 amod malignant,NHL
spaCy_R25 spaCy_T25 spaCy_T24 acl achieved,results
spaCy_R250 spaCy_T250 spaCy_T251 compound immunoblastic,NHL
spaCy_R251 spaCy_T251 spaCy_T246 pobj NHL,for
spaCy_R252 spaCy_T252 spaCy_T251 punct (,NHL
spaCy_R253 spaCy_T253 spaCy_T251 nmod n,NHL
spaCy_R254 spaCy_T254 spaCy_T255 punct =,57
spaCy_R255 spaCy_T255 spaCy_T253 prep 57,n
spaCy_R256 spaCy_T256 spaCy_T251 punct ),NHL
spaCy_R257 spaCy_T257 spaCy_T230 punct ",",rates
spaCy_R258 spaCy_T258 spaCy_T259 compound centroblastic,NHL
spaCy_R259 spaCy_T259 spaCy_T230 appos NHL,rates
spaCy_R26 spaCy_T26 spaCy_T25 prep during,achieved
spaCy_R260 spaCy_T260 spaCy_T263 punct (,35
spaCy_R261 spaCy_T261 spaCy_T263 advmod n,35
spaCy_R262 spaCy_T262 spaCy_T263 punct =,35
spaCy_R263 spaCy_T263 spaCy_T259 appos 35,NHL
spaCy_R264 spaCy_T264 spaCy_T259 punct ),NHL
spaCy_R265 spaCy_T265 spaCy_T259 cc and,NHL
spaCy_R266 spaCy_T266 spaCy_T259 conj NHL,NHL
spaCy_R267 spaCy_T267 spaCy_T223 prep with,achieve
spaCy_R268 spaCy_T268 spaCy_T269 amod uncertain,classification
spaCy_R269 spaCy_T269 spaCy_T267 pobj classification,with
spaCy_R27 spaCy_T27 spaCy_T28 det the,period
spaCy_R270 spaCy_T270 spaCy_T221 punct ",",contributed
spaCy_R271 spaCy_T271 spaCy_T280 mark whereas,has
spaCy_R272 spaCy_T272 spaCy_T273 det the,cc-NHL
spaCy_R273 spaCy_T273 spaCy_T280 nsubj cc-NHL,has
spaCy_R274 spaCy_T274 spaCy_T277 punct (,36
spaCy_R275 spaCy_T275 spaCy_T277 advmod n,36
spaCy_R276 spaCy_T276 spaCy_T277 punct =,36
spaCy_R277 spaCy_T277 spaCy_T273 appos 36,cc-NHL
spaCy_R278 spaCy_T278 spaCy_T273 punct ),cc-NHL
spaCy_R279 spaCy_T279 spaCy_T280 nsubj hitherto,has
spaCy_R28 spaCy_T28 spaCy_T26 pobj period,during
spaCy_R280 spaCy_T280 spaCy_T221 advcl has,contributed
spaCy_R281 spaCy_T281 spaCy_T284 det a,prognosis
spaCy_R282 spaCy_T282 spaCy_T283 advmod relatively,unfavorable
spaCy_R283 spaCy_T283 spaCy_T284 amod unfavorable,prognosis
spaCy_R284 spaCy_T284 spaCy_T280 dobj prognosis,has
spaCy_R285 spaCy_T285 spaCy_T280 prep with,has
spaCy_R286 spaCy_T286 spaCy_T287 advmod only,29
spaCy_R287 spaCy_T287 spaCy_T288 nummod 29,%
spaCy_R288 spaCy_T288 spaCy_T285 pobj %,with
spaCy_R289 spaCy_T289 spaCy_T221 punct .,contributed
spaCy_R29 spaCy_T29 spaCy_T28 prep of,period
spaCy_R3 spaCy_T3 spaCy_T2 cc and,polychemotherapy
spaCy_R30 spaCy_T30 spaCy_T29 pobj 1976,of
spaCy_R31 spaCy_T31 spaCy_T30 cc and,1976
spaCy_R32 spaCy_T32 spaCy_T30 conj 1982,1976
spaCy_R33 spaCy_T33 spaCy_T28 prep in,period
spaCy_R34 spaCy_T34 spaCy_T35 nummod 272,patients
spaCy_R35 spaCy_T35 spaCy_T33 pobj patients,in
spaCy_R36 spaCy_T36 spaCy_T35 prep with,patients
spaCy_R37 spaCy_T37 spaCy_T39 poss non-Hodgkin,lymphomas
spaCy_R38 spaCy_T38 spaCy_T37 case 's,non-Hodgkin
spaCy_R39 spaCy_T39 spaCy_T36 pobj lymphomas,with
spaCy_R4 spaCy_T4 spaCy_T5 amod large-field,radiotherapy
spaCy_R40 spaCy_T40 spaCy_T39 punct (,lymphomas
spaCy_R41 spaCy_T41 spaCy_T39 appos NHL,lymphomas
spaCy_R42 spaCy_T42 spaCy_T39 punct ),lymphomas
spaCy_R43 spaCy_T43 spaCy_T39 prep of,lymphomas
spaCy_R44 spaCy_T44 spaCy_T47 amod low,malignancy
spaCy_R45 spaCy_T45 spaCy_T44 cc and,low
spaCy_R46 spaCy_T46 spaCy_T44 conj high,low
spaCy_R47 spaCy_T47 spaCy_T43 pobj malignancy,of
spaCy_R48 spaCy_T48 spaCy_T20 punct .,promoted
spaCy_R49 spaCy_T49 spaCy_T75 prep In,increased
spaCy_R5 spaCy_T5 spaCy_T2 conj radiotherapy,polychemotherapy
spaCy_R50 spaCy_T50 spaCy_T49 pobj case,In
spaCy_R51 spaCy_T51 spaCy_T50 prep of,case
spaCy_R52 spaCy_T52 spaCy_T56 nmod centroblastic-centrocytic,NHL
spaCy_R53 spaCy_T53 spaCy_T56 punct (,NHL
spaCy_R54 spaCy_T54 spaCy_T56 nmod cb/cc,NHL
spaCy_R55 spaCy_T55 spaCy_T56 punct ),NHL
spaCy_R56 spaCy_T56 spaCy_T51 pobj NHL,of
spaCy_R57 spaCy_T57 spaCy_T56 prep of,NHL
spaCy_R58 spaCy_T58 spaCy_T57 pobj stages,of
spaCy_R59 spaCy_T59 spaCy_T61 compound II,A
spaCy_R6 spaCy_T6 spaCy_T5 prep of,radiotherapy
spaCy_R60 spaCy_T60 spaCy_T61 compound A/III,A
spaCy_R61 spaCy_T61 spaCy_T56 conj A,NHL
spaCy_R62 spaCy_T62 spaCy_T61 punct ",",A
spaCy_R63 spaCy_T63 spaCy_T65 det the,survival
spaCy_R64 spaCy_T64 spaCy_T65 amod recurrence-free,survival
spaCy_R65 spaCy_T65 spaCy_T75 nsubj survival,increased
spaCy_R66 spaCy_T66 spaCy_T65 prep after,survival
spaCy_R67 spaCy_T67 spaCy_T75 amod radiotherapy,increased
spaCy_R68 spaCy_T68 spaCy_T75 punct (,increased
spaCy_R69 spaCy_T69 spaCy_T71 amod n,21
spaCy_R7 spaCy_T7 spaCy_T10 poss non-Hodgkin,]
spaCy_R70 spaCy_T70 spaCy_T71 punct =,21
spaCy_R71 spaCy_T71 spaCy_T75 nsubjpass 21,increased
spaCy_R72 spaCy_T72 spaCy_T75 punct ),increased
spaCy_R73 spaCy_T73 spaCy_T75 aux could,increased
spaCy_R74 spaCy_T74 spaCy_T75 auxpass be,increased
spaCy_R75 spaCy_T75 spaCy_T75 ROOT increased,increased
spaCy_R76 spaCy_T76 spaCy_T75 prep by,increased
spaCy_R77 spaCy_T77 spaCy_T79 det the,method
spaCy_R78 spaCy_T78 spaCy_T79 amod combined,method
spaCy_R79 spaCy_T79 spaCy_T76 pobj method,by
spaCy_R8 spaCy_T8 spaCy_T7 case 's,non-Hodgkin
spaCy_R80 spaCy_T80 spaCy_T83 punct (,25
spaCy_R81 spaCy_T81 spaCy_T83 advmod n,25
spaCy_R82 spaCy_T82 spaCy_T83 punct =,25
spaCy_R83 spaCy_T83 spaCy_T79 appos 25,method
spaCy_R84 spaCy_T84 spaCy_T83 punct ),25
spaCy_R85 spaCy_T85 spaCy_T75 prep from,increased
spaCy_R86 spaCy_T86 spaCy_T87 nummod 17,%
spaCy_R87 spaCy_T87 spaCy_T85 pobj %,from
spaCy_R88 spaCy_T88 spaCy_T75 prep to,increased
spaCy_R89 spaCy_T89 spaCy_T90 nummod 60,%
spaCy_R9 spaCy_T9 spaCy_T10 compound lymphoma,]
spaCy_R90 spaCy_T90 spaCy_T88 pobj %,to
spaCy_R91 spaCy_T91 spaCy_T75 punct ",",increased
spaCy_R92 spaCy_T92 spaCy_T75 cc and,increased
spaCy_R93 spaCy_T93 spaCy_T94 det the,probability
spaCy_R94 spaCy_T94 spaCy_T100 nsubjpass probability,improved
spaCy_R95 spaCy_T95 spaCy_T94 prep of,probability
spaCy_R96 spaCy_T96 spaCy_T97 amod seven-year,survival
spaCy_R97 spaCy_T97 spaCy_T95 pobj survival,of
spaCy_R98 spaCy_T98 spaCy_T100 aux could,improved
spaCy_R99 spaCy_T99 spaCy_T100 auxpass be,improved